SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its 510(k) submission related to prior design changes made to the Zio […]
The post iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio AT Device first appeared on San Francisco News.
Author : SanFrancisco
Publish date : 2024-10-22 08:19:18
Copyright for syndicated content belongs to the linked Source.